MARKET

SRGA

SRGA

RTI Surgical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.920
+0.020
+1.05%
After Hours: 1.920 0 0.00% 16:00 09/25 EDT
OPEN
1.850
PREV CLOSE
1.900
HIGH
1.940
LOW
1.850
VOLUME
367.52K
TURNOVER
--
52 WEEK HIGH
5.40
52 WEEK LOW
1.460
MARKET CAP
145.83M
P/E (TTM)
-0.5573
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Surgalign Holdings, Inc. to Present at the Sidoti Small Cap Virtual Conference
DEERFIELD, Ill., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced that the management team will participate in the Sidoti Small Cap Virtual Conference on Thursday
GlobeNewswire · 09/10 21:05
Surgalign Holdings, Inc. to Present at the Cantor Virtual Global Healthcare Conference
DEERFIELD, Ill., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced that the management team will participate in the Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 17, 2020. The Company is scheduled to present at the conference at 2:40 p.m. Eastern Time the same day via webcast. A live audio webcast of the conference presentation will be available online through the investor relations page of the Company’s website at surgalign.com/investors/. A replay of the webcast will be archived on the website for approximately 90 days.About Surgalign Holdings, Inc. Surgalign Holdings, Inc. is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company is building off a legacy of high quality and differentiated products, and continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient’s lives. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign, a member of AdvaMed, is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Marquette, MI, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.Forward Looking Statement This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign’s website at www.surgalign.com or the SEC’s website at www.sec.gov.Jonathon Singer Investor and Media Contact jsinger@surgalign.com ‪+1 224 303 4651
GlobeNewswire · 09/04 13:30
Surgalign Names Douglas S. Bireley, Executive Vice President, Marketing and Research & Development
DEERFIELD, Ill., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced the appointment of Douglas S. Bireley as Executive Vice President, Marketing and Research
GlobeNewswire · 08/17 21:26
Surgalign Names Douglas S. Bireley As Vice President of Marketing And Research & Development
Benzinga · 08/17 20:27
Surgalign EPS misses by $0.09, beats on revenue
Surgalign (NASDAQ:SRGA): Q2 Non-GAAP EPS of -$0.35 misses by $0.09; GAAP EPS of -$0.74 misses by $0.47. Revenue of $54.2M (-33.6% Y/Y) beats by $7.28M. Pre
seekingalpha · 08/07 16:15
Surgalign Holdings, Inc. Announces Second Quarter 2020 Results
DEERFIELD, Ill., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today reported operating results for the second quarter of 2
GlobeNewswire · 08/07 11:00
Surgalign Holdings, Inc. Announces Date Change for Second Quarter 2020 Earnings Release and Conference Call
DEERFIELD, Ill., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced that it is changing its earnings release and
GlobeNewswire · 08/03 20:05
Surgalign Holdings, Inc. Schedules Second Quarter 2020 Earnings Call for August 4, 2020
DEERFIELD, Ill., July 27, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced it plans to release financial results from t
GlobeNewswire · 07/27 20:05
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRGA. Analyze the recent business situations of RTI Surgical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRGA stock price target is 5.50 with a high estimate of 6.00 and a low estimate of 5.00.
EPS
Institutional Holdings
Institutions: 140
Institutional Holdings: 48.15M
% Owned: 63.39%
Shares Outstanding: 75.95M
TypeInstitutionsShares
Increased
31
4.28M
New
31
-1.85M
Decreased
20
2.23M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.16%
Healthcare Equipment & Supplies
+2.01%
Key Executives
President/Chief Executive Officer/Director
Michael Nefkens
Chairman/Director
Stuart Simpson
President/Chief Executive Officer/Director
Terry Rich
Chief Financial Officer/Chief Operating Officer
Jonathon Singer
Executive Vice President
Bryan Cornwall
Executive Vice President
Roger Rose
Executive Vice President
John Varela
Vice President - Finance/Controller
Ryan Bartolucci
Secretary
Thomas Rose
Vice President
Olivier Visa
Other
Scott Durall
Lead Director/Independent Director
Mark Stolper
Director
Brian Kushner
Independent Director
Jeffrey Lightcap
Independent Director
Thomas McEachin
Independent Director
Paul Thomas
Independent Director
Philip Chapman
Independent Director
Nicholas Valeriani
Independent Director
Adrian Smith
Independent Director
Shirley Weis
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SRGA
Surgalign Holdings, Inc., formerly RTI Surgical Holdings, Inc., is a global medical technology company. The Company offers spine solutions. It offers surgeons a portfolio of clinical solutions, including Coflex Interlaminar stabilization device, SImmetry Sacroiliac Joint Fusion System and Fortilink intervertebral body fusion (IBF) System with TETRAfuse three dimension (3D) technology. It offers its products for various procedures, including decompression with interlaminar stabilization, laminoplasty, minimally Invasive (MIS) thoracolumbar fusion, posterior cervical fusion, posterior thoracolumbar fusion and sacroiliac joint (SIJ) fusion. Its product categories include cervical fixation, TL fixation, motion preservation, Orthobiologics, cervical IBF, TL IBF, sacroiliac (SI) joint fusion and access/instrumentation.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Surgalign Holdings Inc stock information, including NASDAQ:SRGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRGA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRGA stock methods without spending real money on the virtual paper trading platform.